Literature DB >> 33889673

Using the Cecal Ligation and Puncture Model of Sepsis to Induce Rats to Multiple Organ Dysfunction.

Jose Manuel Cóndor Capcha1,2, Roberto S Moreira3, Camila E Rodrigues1, Marcelo A D Silveira1, Lucia Andrade1, Samirah A Gomes2.   

Abstract

Sepsis is a dysregulated hyperinflammatory disease caused by infection. Sepsis leads to multiple organ dysfunction syndrome (MODS), which is associated with high rates of mortality. The cecal ligation and puncture (CLP) model has been widely used in animals and has become the gold-standard method of replicating features of sepsis in humans. Despite several studies and modified CLP protocols, there are still open questions regarding the multifactorial determinants of its reproducibility and medical significance. In our protocol, which is also aimed at mimicking the sepsis observed in clinical practice, male Wistar rats are submitted to CLP with adequate fluid resuscitation (0.15 M NaCl, 25 ml/kg BW i.p.) immediately after surgery. At 6 h after CLP, additional fluid therapy (0.15 M NaCl, 25 ml/kg BW s.c.) and antibiotic therapy with imipenem-cilastatin (single dose of 14 mg/kg BW s.c.) are administered. The timing of the fluid and antibiotic therapy correspond to the initial care given when patients are admitted to the intensive care unit. This model of sepsis provides a useful platform for simulating human sepsis and could lay the groundwork for the development of new treatments.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Acute Kidney Injury; Animal Model; Cecal ligation and puncture (CLP); Organ dysfunction; Rats; Sepsis

Year:  2021        PMID: 33889673      PMCID: PMC8054174          DOI: 10.21769/BioProtoc.3979

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  14 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 2.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 3.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

4.  Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis.

Authors:  Roberto S Moreira; Maria Irigoyen; Talita R Sanches; Rildo A Volpini; Niels O S Camara; Denise M Malheiros; Maria H M Shimizu; Antonio C Seguro; Lucia Andrade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

5.  Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.

Authors:  José Manuel Cóndor Capcha; Camila Eleutério Rodrigues; Roberto de Souza Moreira; Marcelo Duarte Silveira; Paulo Dourado; Fernando Dos Santos; Maria Claudia Irigoyen; Leonardo Jensen; Margoth Ramos Garnica; Irene L Noronha; Lúcia Andrade; Samirah Abreu Gomes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-09       Impact factor: 3.619

Review 6.  Sepsis-Associated Acute Kidney Injury: A Problem Deserving of New Solutions.

Authors:  John A Kellum; Xiaoyan Wen; Mark P de Caestecker; Neil A Hukriede
Journal:  Nephron       Date:  2019-04-24       Impact factor: 2.847

7.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model.

Authors:  C C Baker; I H Chaudry; H O Gaines; A E Baue
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

Review 8.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

9.  Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.

Authors:  José M Cóndor; Camila E Rodrigues; Roberto de Sousa Moreira; Daniele Canale; Rildo A Volpini; Maria H M Shimizu; Niels O S Camara; Irene de L Noronha; Lúcia Andrade
Journal:  Stem Cells Transl Med       Date:  2016-06-08       Impact factor: 6.940

Review 10.  Sepsis: A Review of Advances in Management.

Authors:  Jordi Rello; Francisco Valenzuela-Sánchez; Maria Ruiz-Rodriguez; Silvia Moyano
Journal:  Adv Ther       Date:  2017-10-11       Impact factor: 3.845

View more
  1 in total

1.  Alpha-Chymotrypsin Protects Against Acute Lung, Kidney, and Liver Injuries and Increases Survival in CLP-Induced Sepsis in Rats Through Inhibition of TLR4/NF-κB Pathway.

Authors:  Shaymaa Ramzy Senousy; Al-Shaimaa F Ahmed; Dalia A Abdelhafeez; Mohamed Montaser A Khalifa; Mohammed A S Abourehab; Mahmoud El-Daly
Journal:  Drug Des Devel Ther       Date:  2022-09-08       Impact factor: 4.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.